{
    "Trade/Device Name(s)": [
        "Panther Fusion SARS-CoV-2/Flu A/B/RSV assay"
    ],
    "Submitter Information": "Hologic, Inc.",
    "510(k) Number": "K241240",
    "Predicate Device Reference 510(k) Number(s)": [
        "K222736"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF",
        "OOI"
    ],
    "Summary Letter Date": "April 29, 2024",
    "Summary Letter Received Date": "May 3, 2024",
    "Submission Date": "July 3, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-CoV-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "misc"
    ],
    "Analyte(s)": [
        "SARS-CoV-2",
        "Influenza A virus",
        "Influenza B virus",
        "Respiratory Syncytial Virus (RSV)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal (NP) swab",
        "Anterior nasal (AN) swab"
    ],
    "Specimen Container(s)": [
        "Viral Transport Medium (VTM)",
        "Universal Transport Medium (UTM)",
        "Specimen Lysis Tube (STM)",
        "Enhanced Specimen Transport Medium (eSTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "Panther Fusion system"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time reverse transcriptase PCR (RT-PCR)",
        "Automated nucleic acid extraction"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplexed molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Software",
        "System",
        "Reagent",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Panther Fusion SARS-CoV-2/Flu A/B/RSV multiplex RT-PCR assay for qualitative detection of respiratory viruses in NP and AN swabs, including adaptive crosstalk correction software update.",
    "Indications for Use Summary": "Qualitative detection and differentiation of SARS-CoV-2, Influenza A, Influenza B, and RSV nucleic acids from NP and AN swab specimens in symptomatic individuals to aid differential diagnosis of respiratory infections; not intended to detect influenza C.",
    "fda_folder": "Microbiology"
}